Cantor Fitzgerald Maintains Neutral on Sabra Health Care REIT, Raises Price Target to $21
Sabra Health Care REIT, Inc. +0.74%
Sabra Health Care REIT, Inc. SBRA | 20.49 | +0.74% |
Cantor Fitzgerald analyst Richard Anderson maintains Sabra Health Care REIT (NASDAQ:
SBRA) with a Neutral and raises the price target from $20 to $21.
